Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Food Chem Toxicol ; 116(Pt B): 307-314, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29704576

RESUMO

Exposure to aluminum (Al) inhibits bone formation, the principal mechanism possibly due to oxidative stress. However, little data is available that establishes the precise relationship. In this study, Wistar rats were exposed to 0 (GC), 0.4 (GL), 0.8 (GM) or 1.6 (GH) mg/L aluminum trichloride (AlCl3) in drinking water for 90 days, respectively. The concentrations of Al in serum and bone, serum markers of bone metabolism, bone mineral density (BMD) and body weight were measured. Histological changes within femurs were observed by H&E, ALP, and TRACP staining. Oxidative stress markers and JNK apoptotic pathway were detected in bone. The results indicate that AlCl3 exposure decreased BMD, numbers of ALP-positive osteoblasts and serum levels of bone formation markers (B-ALP, PICP and BGP), and caused damaged to the trabecular structure. Serum levels of bone resorption markers (TRACP-5b, CTX-I) and numbers of TRACP-positive osteoclasts increased in GL, but conversely, they decreased in GM and GH. In addition, AlCl3 caused oxidative stress, up-regulated expression of c-Jun and pro-apoptotic factors with increased p-JNK/JNK ratio and down-regulated expression of anti-apoptotic factor Bcl-2 in bone. Taken together, these results indicate that bone impairment caused by AlCl3 is associated with activation of the oxidative stress-mediated JNK apoptotic pathway.


Assuntos
Compostos de Alumínio/toxicidade , Apoptose , Osso e Ossos/efeitos dos fármacos , Cloretos/toxicidade , Sistema de Sinalização das MAP Quinases , Estresse Oxidativo , Fosfatase Alcalina/sangue , Fosfatase Alcalina/metabolismo , Cloreto de Alumínio , Compostos de Alumínio/sangue , Compostos de Alumínio/metabolismo , Animais , Biomarcadores/sangue , Biomarcadores/metabolismo , Peso Corporal , Densidade Óssea/efeitos dos fármacos , Reabsorção Óssea , Osso e Ossos/diagnóstico por imagem , Osso e Ossos/metabolismo , Cloretos/sangue , Cloretos/metabolismo , Colágeno Tipo I/sangue , Água Potável , Ativação Enzimática , Masculino , Osteoblastos/efeitos dos fármacos , Osteoblastos/enzimologia , Osteocalcina/sangue , Osteogênese/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Fragmentos de Peptídeos/sangue , Peptídeos/sangue , Pró-Colágeno/sangue , Ratos Wistar , Fosfatase Ácida Resistente a Tartarato/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA